Daewoong Pharma
KRX:069620

Watchlist Manager
Daewoong Pharma Logo
Daewoong Pharma
KRX:069620
Watchlist
Price: 193 000 KRW 3.04% Market Closed
Market Cap: 2.2T KRW

Operating Margin
Daewoong Pharma

11.6%
Current
9%
Average
6.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
11.6%
=
Operating Profit
172.5B
/
Revenue
1.5T

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
KR
Daewoong Pharma
KRX:069620
2.2T KRW
12%
US
Eli Lilly and Co
NYSE:LLY
965.2B USD
44%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
3%
US
Johnson & Johnson
NYSE:JNJ
506.7B USD
27%
CH
Roche Holding AG
SIX:ROG
252.4B CHF
34%
UK
AstraZeneca PLC
LSE:AZN
210.9B GBP
24%
CH
Novartis AG
SIX:NOVN
203.1B CHF
33%
US
Merck & Co Inc
NYSE:MRK
246.2B USD
38%
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK
42%
IE
Endo International PLC
LSE:0Y5F
202.5B USD
11%
US
Pfizer Inc
NYSE:PFE
147.5B USD
29%
No Stocks Found

Daewoong Pharma
Glance View

Market Cap
2.2T KRW
Industry
Pharmaceuticals

Daewoong Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceuticals. The company is headquartered in Hwaseong, Gyeonggi-Do. The company went IPO on 2002-11-01. The firm's products mainly include antihypertensive drugs, antianemic agents, antidiabetic agents, antiemetic agents, antihistamine agents, antimicrobials, antineoplastics, antiobesity agents, antipyretic agents, analgesic agents, anti-inflammatory agents, biosimilars, remedies for bone and joint diseases, cardiovascular treatments, central nervous system treatments, digestive agents, dermatologic agents, gastrointestinal agents, health supplements and respiratory remedies, among others. The firm distributes its products in domestic and overseas markets.

Intrinsic Value
263 653.11 KRW
Undervaluation 27%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
11.6%
=
Operating Profit
172.5B
/
Revenue
1.5T
What is the Operating Margin of Daewoong Pharma?

Based on Daewoong Pharma's most recent financial statements, the company has Operating Margin of 11.6%.

Back to Top